Entirety Biomedical Closes $1.2 Million Seed Financing to Advance Absorbable Magnesium Implants for Orthopedic FixationDETROIT, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Entirety Biomedical, a Michigan-based medical device startup developing bioabsorbable implant systems with its proprietary Curasorb technology, today announced the closing of a $1.2 million Seed financing round to advance toward first-in-human clinical trials.
